Live news related to VALNEVA stock (FR0004056851): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on VALNEVA mainly cover M&A activity. The stock trades at €2,46 on Euronext Paris, down 3,95% at the last update. This page lists the articles published on VALNEVA stock to track the share price, company announcements and any item likely to influence market perception.
The Lyon-based vaccine laboratory is making a clear recovery mid-morning in a virtually stable SBF 120. This rebound comes as an American bank has jus…
The Lyon-based vaccine laboratory is retreating mid-morning, in a Paris market oriented downwards. The stock lost technical support during the session…
The Lyon-based vaccine laboratory is losing ground at mid-day, in an SBF 120 also trending downward. The stock extends a decline of several weeks and …
In a press release published on October 14, 2026, Valneva announced that members of its executive team will participate in health-focused conferences …
The Lyon-based vaccine laboratory is making a marked recovery at mid-session, in a virtually stable SBF 120. This rebound follows a week marked by the…
The Lyon-based vaccine laboratory is making a sharp recovery mid-morning, with the SBF 120 index also trending upward. This rebound comes after a sign…
The Lyon-based vaccine laboratory is losing ground on Thursday, mid-session, in an SBF 120 also trending downwards. The stock is reacting to the revoc…
The withdrawal follows a supplementary assessment of the benefit-risk profile of Ixchiq in travelers, conducted by the British Commission on Human Med…
The Lyon-based vaccine laboratory rebounds sharply in mid-morning trading, within an upward-trending SBF 120. This recovery comes after several sessio…
The Lyon-based vaccine laboratory is recovering during the session, against the grain of a declining SBF 120. The share is regaining some ground after…
